Literature DB >> 9618609

Prevention of neonatal tetanus.

W P Glezen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9618609      PMCID： PMC1508217          DOI： 10.2105/ajph.88.6.871

Source DB:  PubMed          Journal:  Am J Public Health        ISSN： 0090-0036            Impact factor:   9.308


× No keyword cloud information.
  12 in total

1.  Antibody response to tetanus toxoid 15 years after initial immunization.

Authors:  J R MCCARROLL; I ABRAHAMS; P A SKUDDER
Journal:  Am J Public Health Nations Health       Date:  1962-10

2.  Pandemic Influenza: Confronting a Re-emergent Threat. Proceedings of a meeting. Bethesda, Maryland, 11-13 December 1995.

Authors: 
Journal:  J Infect Dis       Date:  1997-08       Impact factor: 5.226

3.  Single-dose antenatal tetanus immunisation.

Authors:  J P Stanfield; D Gall; P M Bracken
Journal:  Lancet       Date:  1973-02-03       Impact factor: 79.321

4.  Haemophilus influenzae type b-specific antibody in infants after maternal immunization.

Authors:  J A Englund; W P Glezen; C Thompson; R Anwaruddin; C S Turner; G R Siber
Journal:  Pediatr Infect Dis J       Date:  1997-12       Impact factor: 2.129

5.  Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants.

Authors:  J A Englund; I N Mbawuike; H Hammill; M C Holleman; B D Baxter; W P Glezen
Journal:  J Infect Dis       Date:  1993-09       Impact factor: 5.226

6.  Transplacental immunization of the human fetus to tetanus by immunization of the mother.

Authors:  T J Gill; C F Repetti; L A Metlay; B S Rabin; F H Taylor; D S Thompson; A L Cortese
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

7.  Duration of protective immunity conferred by maternal tetanus toxoid immunization: further evidence from Matlab, Bangladesh.

Authors:  M A Koenig; N C Roy; T McElrath; M Shahidullah; B Wojtyniak
Journal:  Am J Public Health       Date:  1998-06       Impact factor: 9.308

8.  Antibody response to serogroup A and C meningococcal polysaccharide vaccines in infants born of mothers vaccinated during pregnancy.

Authors:  J B McCormick; H H Gusmão; S Nakamura; J B Freire; J Veras; G Gorman; J C Feeley; P Wingo
Journal:  J Clin Invest       Date:  1980-05       Impact factor: 14.808

9.  Maternal immunization with Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in The Gambia.

Authors:  K Mulholland; R O Suara; G Siber; D Roberton; S Jaffar; J N'Jie; L Baden; C Thompson; R Anwaruddin; L Dinan; W P Glezen; N Francis; B Fritzell; B M Greenwood
Journal:  JAMA       Date:  1996-04-17       Impact factor: 56.272

10.  In utero immunization of the fetus to tetanus by maternal vaccination during pregnancy.

Authors:  Y Vanderbeeken; M Sarfati; R Bose; G Delespesse
Journal:  Am J Reprod Immunol Microbiol       Date:  1985-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.